Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021
Thoracic Cancer · 2026-05 · 17 (10)
DOI: 10.1111/1759-7714.70302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 15.05.2026. Verfasst von Yuqing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Respiratory Tract Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Respiratory tract cancers account for a large proportion of new cancers and cause a major global health burden.
Objective
This study aimed to analyze global and regional trends in the incidence, mortality, and disability‐adjusted life years (DALYs) of these cancers from 1990 to 2021 and to project future burden to 2040.
Methods
We conducted a cross‐sectional analysis using data from the Global Burden of Disease 2021 study, assessing incidence, mortality, and DALYs globally and across 5 Socio‐demographic Index (SDI) regions, including risk factor attribution and health inequality trends.
Findings
In 2021, there were 2.60 million new cases globally. Between 1990 and 2021, incident cases, deaths, and DALYs increased by 95.01%, 60.48%, and 56.68%, respectively, while age‐standardized rates declined (estimated annual percentage change: −2.39%, −4.37%, −4.98%). By 2040, 2.45 million new cases are projected (67.11% male), with corresponding rates of 53.51, 46.90, and 1001.79 per 100 000. The highest age‐standardized burden was observed in high and high‐middle SDI regions. Smoking was the leading specific risk factor for deaths and DALYs , particularly for tracheal, bronchus, and lung cancer ( TBLC ) and laryngeal cancer ( LC ). Health inequalities increased from 1990 to 2021, especially for TBLC , with the slope inequality index for age‐standardized incidence rate, DALYs rate, and mortality rate rising from 36.54, 878.54, and 34.92 to 51.38, 953.63, and 44.52, respectively.
Conclusion
The absolute burden of respiratory tract cancers continues to rise despite declining rates, with significant inequalities. Enhanced, context‐specific prevention and control strategies are urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Cardiothoracic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Yi Yao, Xinchen Sun, Chi Zhang
Zitieren
APA
Wang, Y., Yao, Y., Sun, X., Yu, D., & Zhang, C. (2026). Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021. Thoracic Cancer, 17(10). https://doi.org/10.1111/1759-7714.70302
Vancouver
Wang Y, Yao Y, Sun X, Yu D, Zhang C. Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021. Thoracic Cancer. 2026;17(10). doi:10.1111/1759-7714.70302
BibTeX
@article{Wang2026,
author = {Wang, Yuqing and Yao, Yi and Sun, Xinchen and Yu, Di and Zhang, Chi},
title = {Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021},
journal = {Thoracic Cancer},
year = {2026},
volume = {17},
number = {10},
doi = {10.1111/1759-7714.70302}
}
EUVIMED